Strona 4 - Najlepsi lekarze do leczenia gruczolakoraka – TOP 106 lekarzy

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr Kinas specjalizuje się w złożonych operacjach onkologicznych w Büyük Anadolu Hospitals, w tym w zabiegach trzustki i dróg żółciowych.

• Ekspert w chirurgii onkologicznej, ze szczególnym uwzględnieniem nowotworów układu pokarmowego
• Wykonuje zaawansowane operacje bariatryczne i metaboliczne
• Specjalizuje się w operacjach raka piersi i tarczycy

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr Michael Van Kampen specjalizuje się wyłącznie w radioterapii i oferuje celowane podejście do leczenia w klinice Nordwest.

• Skupia się na technikach precyzyjnej radioterapii
• Pracuje z wykorzystaniem zaawansowanych technologii radioterapeutycznych
• Należy do wielodyscyplinarnego zespołu onkologicznego

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Kieruje całym Centrum Onkologii jako lekarz naczelny w Centrum Medycznym Assuta.

• Specjalizuje się w onkologii klinicznej i leczeniu nowotworów
• Posiada bogate doświadczenie w prowadzeniu złożonych przypadków onkologicznych
• Nadzoruje opiekę nad pacjentami i protokoły medyczne w wiodącym oddziale onkologii

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr Zalmanova specjalizuje się w radioterapii, ze szczególnym uwzględnieniem gruczolakoraka w Centrum Medycznym Assuta.

• Radioterapeuta z doświadczeniem w celowanym leczeniu promieniowaniem
• Pracuje w Centrum Medycznym Assuta, znanym z zaawansowanej opieki onkologicznej
• Koncentruje się na spersonalizowanych planach leczenia dla pacjentów z gruczolakorakiem

Dr Karen Drumea jest specjalistką radioterapii i onkologiem w Centrum Medycznym Rambam. W swojej pracy skupia się na precyzyjnych i skutecznych planach leczenia.

• Specjalizuje się w radioterapii gruczolakoraka
• Pracuje w Centrum Medycznym Rambam, wiodącej placówce opieki zdrowotnej
• Zapewnia pacjentom spersonalizowaną opiekę medyczną

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr Derin jest autorem ponad 30 publikacji naukowych na temat leczenia nowotworów złośliwych. Jest uznanym ekspertem wśród tureckich i europejskich onkologów.

• Główny specjalista onkologii klinicznej w szpitalu Liv Hospital Ulus
• Ekspert w dziedzinie nowotworów układu pokarmowego, płuc oraz nowotworów ginekologicznych, takich jak rak macicy i jajnika
• Autor ponad 30 krajowych i międzynarodowych prac badawczych
• Aktywny członek Europejskiego Towarzystwa Onkologii Klinicznej (ESMO)
• Docent z bogatym doświadczeniem klinicznym i akademickim

Doc. dr Murat Ayhan specjalizuje się w onkologii molekularnej i immunoterapii w szpitalu Liv Vadistanbul, koncentrując się na leczeniu zaawansowanego gruczolakoraka.

• Prowadzi szeroko zakrojone badania w ramach prób klinicznych fazy II i III dotyczących raka piersi oraz płuc
• Opublikował liczne prace na temat wyników leczenia nowotworów oraz wpływu COVID-19
• Jest członkiem Europejskiego Towarzystwa Onkologii Klinicznej (ESMO) oraz Tureckiego Towarzystwa Onkologii Klinicznej
• Jest autorem rozdziałów dotyczących terapii celowanych w podręcznikach onkologii klinicznej

Dr Tarkan specjalizuje się w złożonych operacjach raka żołądka, łącząc precyzję chirurgiczną z najnowszymi osiągnięciami w onkologii.

• Członek Tureckiego Towarzystwa Chirurgii Bariatrycznej
• Afiliowany przy Międzynarodowej Federacji Chirurgii Otyłości i Zaburzeń Metabolicznych
• Absolwent Wydziału Lekarskiego Uniwersytetu Dicle

Dr Lee Kwang Beom jest onkoginekologiem specjalizującym się w chirurgii laparoskopowej w Gachon University Gil Medical Center.

• Specjalista w operacjach laparoskopowych w leczeniu nowotworów
• Koncentruje się w szczególności na przypadkach onkologii ginekologicznej
• Stosuje małoinwazyjne techniki chirurgiczne

Specjalizuje się w zaawansowanych technikach laserowych w procedurach urologicznych, w tym w leczeniu prostaty i pęcherza moczowego w Centrum Chirurgii Dievo.

• Wykonuje laserową enukleację i waporyzację prostaty
• Ekspert w małoinwazyjnych technikach usuwania kamieni nerkowych
• Biegły w laparoskopowej radykalnej nefrektomii oraz plastyce połączenia miedniczkowo-moczowodowego
• Przeprowadza złożone rekonstrukcje cewki moczowej i operacje naprawcze pęcherza moczowego